Debottam Sinha

1.1k total citations
28 papers, 783 citations indexed

About

Debottam Sinha is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Debottam Sinha has authored 28 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Debottam Sinha's work include Microtubule and mitosis dynamics (5 papers), Cancer-related Molecular Pathways (5 papers) and CAR-T cell therapy research (4 papers). Debottam Sinha is often cited by papers focused on Microtubule and mitosis dynamics (5 papers), Cancer-related Molecular Pathways (5 papers) and CAR-T cell therapy research (4 papers). Debottam Sinha collaborates with scholars based in Australia, United Kingdom and India. Debottam Sinha's co-authors include Kum Kum Khanna, Murugan Kalimutho, Pascal H. G. Duijf, Sriganesh Srihari, Jessie Jeffery, Deepak Mittal, Prahlad V. Raninga, Amanda L. Bain, Kimberley Stannard and Mark J. Smyth and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Debottam Sinha

27 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debottam Sinha Australia 14 426 296 137 128 120 28 783
Sandra Muñoz-Galván Spain 18 661 1.6× 387 1.3× 67 0.5× 132 1.0× 215 1.8× 40 1.0k
Sahithi Pamarthy United States 19 481 1.1× 227 0.8× 121 0.9× 62 0.5× 131 1.1× 23 830
Ukhyun Jo United States 20 782 1.8× 458 1.5× 71 0.5× 91 0.7× 148 1.2× 44 984
Anna M. Chiarella United States 8 652 1.5× 322 1.1× 114 0.8× 57 0.4× 282 2.4× 13 967
Zi‐Jie Long China 13 586 1.4× 300 1.0× 149 1.1× 278 2.2× 197 1.6× 29 1000
Marion Leduc France 15 258 0.6× 207 0.7× 172 1.3× 93 0.7× 78 0.7× 34 786
Quanhong Sun United States 16 599 1.4× 264 0.9× 109 0.8× 65 0.5× 164 1.4× 28 936
Johanna Tuomela Finland 19 537 1.3× 327 1.1× 188 1.4× 65 0.5× 179 1.5× 49 984
Tatsiana Kosciuk United States 10 317 0.7× 216 0.7× 119 0.9× 153 1.2× 110 0.9× 10 677
Joshua T. Burgess Australia 14 609 1.4× 455 1.5× 93 0.7× 53 0.4× 172 1.4× 31 933

Countries citing papers authored by Debottam Sinha

Since Specialization
Citations

This map shows the geographic impact of Debottam Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debottam Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debottam Sinha more than expected).

Fields of papers citing papers by Debottam Sinha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debottam Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debottam Sinha. The network helps show where Debottam Sinha may publish in the future.

Co-authorship network of co-authors of Debottam Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Debottam Sinha. A scholar is included among the top collaborators of Debottam Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debottam Sinha. Debottam Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wright, Quentin G., Debottam Sinha, James W. Wells, et al.. (2024). Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity. Journal for ImmunoTherapy of Cancer. 12(1). e007960–e007960. 2 indexed citations
2.
Zaugg, Julian, Rodney C. Straw, Debottam Sinha, et al.. (2024). Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs. mSphere. 9(4). e0055523–e0055523. 2 indexed citations
3.
Ramanathan, Gnanasambandan, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, et al.. (2023). Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients. Medical Oncology. 40(5). 149–149. 16 indexed citations
4.
Shohayeb, Belal, Amanda L. Bain, Patrick R.J. Fortuna, et al.. (2021). Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis. PLoS Genetics. 17(10). e1009334–e1009334. 3 indexed citations
5.
Sinha, Debottam, Sriganesh Srihari, Laëtitia Le Texier, et al.. (2021). 'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies. Journal for ImmunoTherapy of Cancer. 9(2). e001608–e001608. 13 indexed citations
6.
Raninga, Prahlad V., Andy Lee, Debottam Sinha, et al.. (2020). Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition. Theranostics. 10(12). 5259–5275. 52 indexed citations
7.
Sinha, Debottam, Purba Nag, Devathri Nanayakkara, et al.. (2020). Cep55 overexpression promotes genomic instability and tumorigenesis in mice. Communications Biology. 3(1). 593–593. 24 indexed citations
8.
Sinha, Debottam, Corey Smith, & Rajiv Khanna. (2020). Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors. Trends in Molecular Medicine. 27(1). 75–90. 3 indexed citations
9.
Kalimutho, Murugan, Debottam Sinha, Deepak Mittal, et al.. (2019). Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 85–85. 14 indexed citations
10.
Raninga, Prahlad V., Andy Chao Hsuan Lee, Debottam Sinha, et al.. (2019). Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti‐PD‐L1 antibody for treatment of triple‐negative breast cancer. International Journal of Cancer. 146(1). 123–136. 70 indexed citations
11.
Raninga, Prahlad V., et al.. (2019). Synergistic anti-cancer activity of auranofin with anti-PD-L1 therapy in triple negative breast cancer. Annals of Oncology. 30. v3–v3. 3 indexed citations
12.
Sinha, Debottam, Pascal H. G. Duijf, & Kum Kum Khanna. (2019). Mitotic slippage: an old tale with a new twist. Cell Cycle. 18(1). 7–15. 97 indexed citations
13.
Kalimutho, Murugan, Debottam Sinha, Jessie Jeffery, et al.. (2018). CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer. EMBO Molecular Medicine. 10(9). 63 indexed citations
14.
Sinha, Debottam, Murugan Kalimutho, Josephine Bowles, et al.. (2018). Cep55 overexpression causes male‐specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling. The FASEB Journal. 32(9). 4984–4999. 40 indexed citations
15.
Sinha, Debottam, et al.. (2017). Synergistic inhibition of CEP55 induces mitotic catastrophe and specifically targets aggressive breast cancer. Annals of Oncology. 28. v583–v583. 1 indexed citations
16.
Mittal, Deepak, Debottam Sinha, Deborah S. Barkauskas, et al.. (2016). Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis. Cancer Research. 76(15). 4372–4382. 142 indexed citations
17.
Jeffery, Jessie, Debottam Sinha, Sriganesh Srihari, Murugan Kalimutho, & Kum Kum Khanna. (2015). Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis. Oncogene. 35(6). 683–690. 108 indexed citations
18.
19.
Ghazal‐Aswad, Saad, M.J. Tilby, M. Lind, et al.. (1999). Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels. Annals of Oncology. 10(3). 329–334. 18 indexed citations
20.
Ghazal‐Aswad, Saad, M.J. Millward, N P Bailey, et al.. (1996). Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancer.. Journal of Clinical Oncology. 14(3). 800–805. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Muñoz-Galván Breakdown of academic impact, for papers by Sahithi Pamarthy Breakdown of academic impact, for papers by Ukhyun Jo Breakdown of academic impact, for papers by Anna M. Chiarella Breakdown of academic impact, for papers by Zi‐Jie Long Breakdown of academic impact, for papers by Marion Leduc Breakdown of academic impact, for papers by Quanhong Sun Breakdown of academic impact, for papers by Johanna Tuomela Breakdown of academic impact, for papers by Tatsiana Kosciuk Breakdown of academic impact, for papers by Joshua T. Burgess
Rankless by CCL
2026